Exploratory experiment designed to discover new patterns targeting HDAC4, NHE6, LRP1 in unspecified model. Primary outcome: HDAC4 nuclear translocation inhibition and NHE6 expression restoration
This experiment investigated the molecular mechanism by which SAHA@LIPO-ANG2 nanoparticles inhibit HDAC4 nuclear translocation and restore NHE6 expression. The study examined how HDAC4 acts as an upstream transcriptional repressor of sodium-hydrogen exchanger 6 (NHE6), and how inhibiting HDAC4 restores NHE6 expression. The researchers validated that restoration of NHE6 expression corrects endosomal hyperacidification and rescues trafficking and plasma membrane expression of LRP1, a key Aβ clearance receptor. This work established the HDAC4-NHE6-pH regulatory axis as a critical pathway in amyloid clearance mechanisms.
Treatment with SAHA@LIPO-ANG2 nanoparticles, assessment of HDAC4 nuclear translocation, measurement of NHE6 expression levels, evaluation of endosomal pH and LRP1 trafficking
Inhibition of HDAC4 nuclear translocation would restore NHE6 expression and normalize endosomal pH
Reduced HDAC4 nuclear translocation, increased NHE6 expression, normalized endosomal pH, restored LRP1 plasma membrane expression
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.